02.12.2016
- AstraZeneca’s biologics R&D arm MedImmune and US life sciences group Abpro have spun out a new company – AbMed – to advance the development of a preclinical, novel bispecific...
04.10.2016
- Bayer and Evotec have signed a five-year multi-research pact to develop multiple clinical candidates to treat chronic kidney diseases. Both of the German companies will contribute...
28.04.2016
- French biotechnology company Abivax has signed a contract with API manufacturer PCAS group for the production and supply of ABX464, a drug candidate for treating HIV. Under the...
28.04.2016
- As part of a newly announced collaboration with non-profit scientific institutes and high-tech companies, British-Swedish drugmaker AstraZeneca and its global biologics research...
16.10.2015
- Canada’s enGne, a gene therapy company focused on development of therapeutics using its proprietary “Gene Pill”, and Janssen Biotech, one of the Janssen Pharmaceutical Companies of...
08.06.2015
- In a new international clinical trial, two cancer drugs developed by US drugmaker Bristol-Myers Squibb are reported to have shrunk tumors in nearly 60% of people with advanced...
